Thursday, August 17

12pm EST / 11am CST / 9am PST

An analysis on the utility of liquid biopsy (LBx) throughout clinical development

Attend our live webinar!

Hear from leading experts on the utility of liquid biopsy in research and drug development, including complementary and longitudinal testing, discovery of additional actionable variants, and more. Tempus SVP of Life Science Pathology, Nike Beaubier, MD, will be joined by Tempus Chief Medical Officer of Oncology, Ezra Cohen, MD, and Tempus General Manager and Executive Vice President, Mike Yasiejko.

Register now to join the live event and receive a recording of the session.


Featured Speakers

Nike Beaubier, MD

Senior Vice President, Life Science Pathology

Ezra Cohen, MD

Chief Medical Officer of Oncology

Mike Yasiejko

General Manager and Executive Vice President